BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19692106)

  • 21. Impact of delays in cell infection and virus production on HIV-1 dynamics.
    Zhu H; Zou X
    Math Med Biol; 2008 Jun; 25(2):99-112. PubMed ID: 18504248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Screening of HIV-1 replication inhibitors by using pseudotyped virus system].
    Cao YL; Guo Y
    Yao Xue Xue Bao; 2008 Mar; 43(3):253-8. PubMed ID: 18630260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection.
    Liao CH; Kuang YQ; Liu HL; Zheng YT; Su B
    AIDS; 2007 Dec; 21 Suppl 8():S19-26. PubMed ID: 18172386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance of monocyte to HIV-1 infection is not due to uncoating defect.
    Srichatrapimuk S; Auewarakul P
    Virus Res; 2007 Jun; 126(1-2):277-81. PubMed ID: 17399836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of hepatitis C virus-infected, monocyte lineage reservoirs in individuals with or without HIV coinfection.
    Coquillard G; Patterson BK
    J Infect Dis; 2009 Sep; 200(6):947-54. PubMed ID: 19678757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ingestion of the malaria pigment hemozoin renders human macrophages less permissive to HIV-1 infection.
    Diou J; Gauthier S; Tardif MR; Fromentin R; Lodge R; Sullivan DJ; Tremblay MJ
    Virology; 2009 Dec; 395(1):56-66. PubMed ID: 19801158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages.
    Mikulak J; Gianolini M; Versmisse P; Pancino G; Lusso P; Verani A
    Virology; 2009 Jul; 390(1):37-44. PubMed ID: 19447459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53.
    Levine AJ
    Virology; 2009 Feb; 384(2):285-93. PubMed ID: 19081592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms.
    Cassol E; Cassetta L; Rizzi C; Alfano M; Poli G
    J Immunol; 2009 May; 182(10):6237-46. PubMed ID: 19414777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential HIV-1 integration targets more actively transcribed host genes in neonatal than adult blood mononuclear cells.
    Wellensiek BP; Ramakrishnan R; Sundaravaradan V; Mehta R; Harris DT; Ahmad N
    Virology; 2009 Mar; 385(1):28-38. PubMed ID: 19100594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Towards a vaccine for HIV infection: role of the gp41 envelope protein].
    Debre P; Costagliola D; Legrand R; Vieillard V
    Bull Acad Natl Med; 2009 Jan; 193(1):127-36; discussion 137-8. PubMed ID: 19718985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective infection of CD4+ effector memory T lymphocytes leads to preferential depletion of memory T lymphocytes in R5 HIV-1-infected humanized NOD/SCID/IL-2Rgammanull mice.
    Nie C; Sato K; Misawa N; Kitayama H; Fujino H; Hiramatsu H; Heike T; Nakahata T; Tanaka Y; Ito M; Koyanagi Y
    Virology; 2009 Nov; 394(1):64-72. PubMed ID: 19744686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and characterization of a porcine monocytic cell line supporting porcine reproductive and respiratory syndrome virus (PRRSV) replication and progeny virion production by using an improved DNA-launched PRRSV reverse genetics system.
    Huang YW; Fang Y; Meng XJ
    Virus Res; 2009 Oct; 145(1):1-8. PubMed ID: 19505514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Different sensitivity of productively HIV-I infected and non-infected cells to apoptosis].
    Boĭchuk SV; Ivanov AV; Mustafin Ig; Makarova MV; Dunaev PD; Aleksander L
    Patol Fiziol Eksp Ter; 2008; (4):7-9. PubMed ID: 19198264
    [No Abstract]   [Full Text] [Related]  

  • 35. Expression of a modified form of CD4 results in the release of an anti-HIV factor derived from the Env sequence.
    Zaldívar I; Muñoz-Fernández MA; Alarcón B; San José E
    J Immunol; 2009 Jul; 183(2):1188-96. PubMed ID: 19553524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV-host interactions: vital to the virus and key to its inhibition.
    Trkola A
    Curr Opin Microbiol; 2004 Aug; 7(4):407-11. PubMed ID: 15358260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein.
    Di Bonito P; Grasso F; Mochi S; Petrone L; Fanales-Belasio E; Mei A; Cesolini A; Laconi G; Conrad H; Bernhard H; Dembek CJ; Cosma A; Santini SM; Lapenta C; Donati S; Muratori C; Giorgi C; Federico M
    Virology; 2009 Dec; 395(1):45-55. PubMed ID: 19800648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leishmania infantum promastigotes reduce entry of HIV-1 into macrophages through a lipophosphoglycan-mediated disruption of lipid rafts.
    Garg R; Lodge R; Descoteaux A; Tremblay MJ
    J Infect Dis; 2008 Jun; 197(12):1701-8. PubMed ID: 18422456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
    Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
    Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T; Moffat JM; Venturi V; Davenport MP; Doherty PC; Turner SJ; Stambas J
    Vaccine; 2009 Nov; 27(48):6755-61. PubMed ID: 19744584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.